175 related articles for article (PubMed ID: 29881461)
1. Connecting genetics and gene expression data for target prioritisation and drug repositioning.
Ferrero E; Agarwal P
BioData Min; 2018; 11():7. PubMed ID: 29881461
[TBL] [Abstract][Full Text] [Related]
2. Turning genome-wide association study findings into opportunities for drug repositioning.
Lau A; So HC
Comput Struct Biotechnol J; 2020; 18():1639-1650. PubMed ID: 32670504
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
4. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
5. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
[TBL] [Abstract][Full Text] [Related]
6. Precision drug repurposing via convergent eQTL-based molecules and pathway targeting independent disease-associated polymorphisms.
Vitali F; Berghout J; Fan J; Li J; Li Q; Li H; Lussier YA
Pac Symp Biocomput; 2019; 24():308-319. PubMed ID: 30864332
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the Promise of Drug Repositioning through Genetics.
Pritchard JE; O'Mara TA; Glubb DM
Front Pharmacol; 2017; 8():896. PubMed ID: 29270124
[TBL] [Abstract][Full Text] [Related]
8. Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunities.
Jhamb D; Magid-Slav M; Hurle MR; Agarwal P
Drug Discov Today; 2019 Jun; 24(6):1232-1236. PubMed ID: 30935985
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
10. A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
Lee SY; Song MY; Kim D; Park C; Park DK; Kim DG; Yoo JS; Kim YH
Front Pharmacol; 2019; 10():1653. PubMed ID: 32063857
[TBL] [Abstract][Full Text] [Related]
11. Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine.
Kim J; Yoo M; Shin J; Kim H; Kang J; Tan AC
Int J Genomics; 2018; 2018():7697356. PubMed ID: 29765977
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry.
So HC; Chau CK; Chiu WT; Ho KS; Lo CP; Yim SH; Sham PC
Nat Neurosci; 2017 Oct; 20(10):1342-1349. PubMed ID: 28805813
[TBL] [Abstract][Full Text] [Related]
13. [Data-driven drug discovery for drug repurposing].
Saito R; Yano N; Kojima S; Miyoshi F
Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
[TBL] [Abstract][Full Text] [Related]
14. PharmGWAS: a GWAS-based knowledgebase for drug repurposing.
Kang H; Pan S; Lin S; Wang YY; Yuan N; Jia P
Nucleic Acids Res; 2024 Jan; 52(D1):D972-D979. PubMed ID: 37831083
[TBL] [Abstract][Full Text] [Related]
15. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
[TBL] [Abstract][Full Text] [Related]
16. A genomics-based systems approach towards drug repositioning for rheumatoid arthritis.
Xu R; Wang Q
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):518. PubMed ID: 27557330
[TBL] [Abstract][Full Text] [Related]
17. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
[TBL] [Abstract][Full Text] [Related]
18. Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs.
Parisi D; Adasme MF; Sveshnikova A; Bolz SN; Moreau Y; Schroeder M
Comput Struct Biotechnol J; 2020; 18():1043-1055. PubMed ID: 32419905
[TBL] [Abstract][Full Text] [Related]
19. Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
Wang H; Gu Q; Wei J; Cao Z; Liu Q
Clin Pharmacol Ther; 2015 May; 97(5):451-4. PubMed ID: 25670647
[TBL] [Abstract][Full Text] [Related]
20. A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis.
Namba S; Konuma T; Wu KH; Zhou W; ; Okada Y
Cell Genom; 2022 Oct; 2(10):100190. PubMed ID: 36778001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
